Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

BBNX - Beta Bionics, Inc. Financial Statements | Finranks

Home

/

BBNX

B

Beta Bionics, Inc. (BBNX)

NGM – Real Time Price. Currency in USD

16.99

-0.63 (-3.58%)

Market open: Aug 12, 2026, 11:40 AM EDT

17.28

-0.34 (-1.91%)

Previous after-hours: Aug 11, 2026, 7:48 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Total Assets

Total Liabilities

Stockholders Equity

Total Debt

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

100M

65M

12M

179K

Cost of goods sold

-45M

-29M

-6M

-2M

Gross Profit

56M

36M

6M

-2M

Operating expenses (excl. COGS)

-127M

-81M

-42M

-64M

Operating Income

-72M

-45M

-36M

-66M

Non-operating income, total

-2M

-10M

-8M

1M

Pretax income

-73M

-55M

-44M

-65M

Equity in earnings

0

0

0

0

Taxes

0

0

0

0

Non-controlling/minority interest

0

0

0

0

After tax other income/expense

0

0

0

0

Net income before discontinued operations

-73M

-55M

-44M

-65M

Discontinued operations

0

0

0

0

Net income

-73M

-55M

-44M

-65M

Dilution adjustment

0

0

0

0

Preferred dividends

0

0

0

0

Name

2025

2024

2023

2022

Total assets

329M+119.7%

150M+36.0%

110M+209.7%

36M

Total current assets

268M

133M

104M

28M

Total non-current assets

61M

17M

6M

7M

Total liabilities

41M-44.1%

74M+43.2%

51M+128.3%

23M

Total current liabilities

31M

21M

11M

9M

Total non-current liabilities

10M

52M

41M

14M

Total equity

288M

76M

59M

13M

Total liabilities & shareholders' equities

329M

150M

110M

36M

Total debt

7M+0.7%

7M+71.8%

4M+2.2%

4M

Name

2025

2024

2023

2022

Cash from operating activities

-51M

-48M

-32M

-60M

Cash from investing activities

-163M

-3M

-70M

-769K

Cash from financing activities

215M

56M

101M

57M

Free cash flow

-56M-8.8%

-52M-57.3%

-33M+46.1%

-61M